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HIV testing among pregnant 
women in Brazil: rates and 
predictors
Testagem anti-HIV em mulheres 
grávidas no Brasil: taxas e preditores
ABSTRACT
OBJECTIVE: To assess rates of offering and uptake of HIV testing and their 
predictors among women who attended prenatal care.
METHODS: A population-based cross-sectional study was conducted among 
postpartum women (N=2,234) who attended at least one prenatal care visit 
in 12 cities. Independent and probabilistic samples were selected in the cities 
studied.  Sociodemographic data, information about prenatal care and access 
to HIV prevention interventions during the current pregnancy were collected. 
Bivariate and multivariate analyses were carried out to assess independent 
effects of the covariates on offering and  uptake of HIV testing. Data collection 
took place between November 1999 and April 2000.
RESULTS: Overall, 77.5% of the women reported undergoing HIV testing 
during the current pregnancy. Offering of HIV testing was positively associated 
with: previous knowledge about prevention of mother-to-child transmission 
of HIV; higher number of prenatal care visits; higher level of education and 
being white. HIV testing acceptance rate was 92.5%.
CONCLUSIONS: The study results indicate that dissemination of information 
about prevention of mother-to-child transmission among women may contribute 
to increasing HIV testing coverage during pregnancy. Non-white women with 
lower level of education should be prioritized. Strategies to increase attendance 
of vulnerable women to prenatal care and to raise awareness among health 
care workers are of utmost importance.
DESCRIPTORS: Pregnant Women. HIV Infections, diagnosis. Acquired 
Immunodefi ciency Syndrome, prevention & control. Prenatal Care. 
Socioeconomic Factors. Cross-Sectional Studies.
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The availability of effective interventions to prevent 
mother-to-child transmission (PMTCT) of HIV infec-
tion makes the identifi cation of HIV-infected pregnant 
women a high priority.2
In 2000, it was estimated that 600,000 people were 
living with HIV/AIDS in Brazil with 0.4% prevalence 
among childbearing women.18 By mid 2006, 433,067 
AIDS cases had been reported to the Brazilian Ministry 
of Health (30% in females).a Overall, three million de-
liveries occur each year in the country, 14,000 among 
HIV-infected women.
Brazil was the fi rst developing country to implement a 
large scale PMTCT program.b Since 1997, the Brazilian 
Ministry of Health has adopted a policy of universal 
offering of HIV testing to pregnant women, coupled 
RESUMO
OBJETIVO: Estimar as taxas de oferta e realização do teste anti-HIV e seus 
preditores entre mulheres que receberam atendimento pré-natal.
MÉTODOS: Foi conduzido estudo transversal, de base populacional, com 
2.234 puérperas em 12 cidades do Brasil. Amostras probabilísticas foram 
selecionadas independentemente por cidade, entre puérperas que compareceram 
a pelo menos uma visita pré-natal. Foram coletados dados sociodemográfi cos, 
informações sobre cuidado pré-natal e acesso a intervenções de prevenção 
do HIV durante a gravidez corrente, com a utilização de um questionário. 
Foram realizadas análises bivariadas e multivariadas para verifi car os efeitos 
independentes das covariáveis na oferta e realização do teste anti-HIV. Os 
dados foram coletados no período de novembro de 1999 a abril de 2000.
RESULTADOS: A realização do teste na gravidez foi relatada por 77,5% 
das entrevistadas. A oferta do teste anti-HIV foi positivamente associada a: 
conhecimento prévio sobre a prevenção da transmissão materno-infantil do 
HIV; maior número de visitas pré-natal; maior nível de escolaridade e ter cor 
da pele branca. A taxa de aceitação do teste anti-HIV foi de 92,5%. 
CONCLUSÕES: Os resultados indicam que a disseminação da informação 
sobre prevenção da transmissão materno-infantil do HIV pode contribuir para 
aumentar a cobertura da testagem anti-HIV durante a gravidez. Mulheres não-
brancas com menores níveis educacionais devem ser priorizadas. Estratégias 
para aumentar a participação de populações vulneráveis ao cuidado pré-natal 
e a sensibilização de trabalhadores de saúde são de grande importância.
DESCRITORES: Gestantes. Infecções por HIV, diagnóstico. Síndrome 
de Imunodefi ciência Adquirida, prevenção e controle. Cuidado Pré-
Natal. Fatores Socioeconômicos. Estudos Transversais.
INTRODUCTION
a Ministério da Saúde. Coordenação Nacional de DST/AIDS. 01ª à 26ª semanas epidemiológicas - janeiro a junho de 2006. Bol Epidemiol 
Aids DST. 2006;3(1).
b Ministério da Saúde. Programa Nacional de Doenças Sexualmente Transmissíveis/AIDS/Secretaria de Assistência à Saúde; Considerações 
gerais do binômio: HIV/Aids e gravidez. Brasília; 1995.
c Ministério da Saúde – Brasil. Portaria Técnica Ministerial N0 874/97 de 03 de julho de 1997, Diário Ofi cial da União. 04 jul 1997.
d Veloso VG, Vasconcelos AL, Grinsztejn B. Prevenção da transmissão vertical no Brasil. Bol Epidemiol AIDS DST. 1999;12(3):16-23. Available 
from: http://www.aids.gov.br/udtv/boletim_jun_ago99/prevenc_trans_vertical.htm
with counseling.c The three components of the Pediatric 
AIDS Clinical Trial Group 076 protocol are free to all 
HIV-infected pregnant women and their newborns.2,d
Despite being crucial to the proper management of 
AIDS programs, evaluation of coverage of PMTCT 
interventions and outcomes are still limited in Brazil. 
The objective of the present study was to assess the rates 
of HIV testing offering and uptake and their predictors 
among women who attended prenatal care.
METHODS
A population-based cross-sectional study was con-
ducted among postpartum women (≥18 years of age) 
who delivered under the coverage of the Sistema Único 
de Saúde (Brazilian Health System, SUS) and who 
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attended at least one prenatal care visit and signed an 
informed consent form. According to Brazilian law, any 
woman younger than 18 years old, if not legally married 
or living with a partner, was only eligible for the study 
if their parents/guardians signed an informed consent 
form. Those women who had experienced an abortion, 
a stillbirth or any other clinical condition preventing an 
interview were excluded from the eligible population 
and from the study.
The study was conducted in 12 Brazilian cities highly 
affected by HIV/AIDS epidemic – Rio de Janeiro, 
Duque de Caxias, São Paulo, Santos, Sorocaba, Campo 
Grande, Brasília, Curitiba, Florianópolis, Itajaí, Porto 
Alegre and Uruguaiana. Twelve independent, 24-hour 
cluster samples, stratifi ed by hospital, were selected.
Every maternity hospital with at least one delivery 
per day comprised a selection stratum. The sample 
size of postpartum women for each city studied was 
determined to estimate the prevalence of HIV testing 
during prenatal care with a relative error varying from 
0.1 to 0.3 (Table 1). The ratio of postpartum women 
sample size by mean daily deliveries covered by SUS 
in the city provided the number of survey days in a city. 
Each survey day corresponded to a cluster in which all 
women who delivered in the previous day, if eligible, 
were interviewed. After the number of clusters was de-
termined, women were randomly selected from the set 
of days of the period of fi eldwork, with equiprobability 
and independently for each maternity hospital.
Since the number of 24-hour clusters was the same in 
all maternity hospitals in a given city, the sample size 
of women was proportionally allocated to the number 
of deliveries per hospital, which lead to a self-weighted 
sample by city.
Postpartum women were approached to participate in 
the study prior to being discharged from the maternity 
hospitals.
All eligible women were invited to participate.
Trained interviewers queried the women using a 
validated questionnaire. Sociodemographic data, 
information about prenatal care service utilization as 
well as access to HIV counseling, testing and preven-
tion interventions during the current pregnancy were 
collected. Data was collected between November 1999 
and April 2000.
Data entry and management were carried out using 
the Integrated Microcomputer Processing System, 
a statistical package developed by the United States 
Bureau of the Census.a
Table 1. Calculated and effective sample size by city. Brazil, 1999–2000.
City
Number of 
hospitals with 
more than one 
delivery per day*
Expected preva-
lence of prenatal 
care coverage
(proportion)
Expected pre-
valence of HIV 
testing coverage
(proportion)
Rela-
tive 
error
Calculated 
sample size 
(postpartum 
women)
Calculated 
number of 
clusters** 
(study days)
Effective 
sample size 
(postpartum 
women)
Brasília 9 0.80 0.30 0.15 254 3 322
Campo Grande 3 0.80 0.05 0.25 153 5 153
Curitiba 13 0.80 0.30 0.15 198 3 213
Duque de Caxias 3 0.60 0.10 0.15 104 4 97
Florianópolis 2 0.65 0.10 0.25 183 14 185
Itajaí 1 0.70 0.50 0.10 113 16 81
Porto Alegre 7 0.75 0.40 0.15 164 2 148
Rio de Janeiro 24 0.60 0.30 0.15 270 2 290
Santos 3 0.60 0.70 0.10 111 7 116
São Paulo 38 0.80 0.40 0.10 464 2 385
Sorocaba 2 0.80 0.70 0.10 126 6 128
Uruguaiana 1 0.80 0.10 0.30 111 18 116
Total 106 - - - 2 251 82 2234
* Based on data from 1997, excluding maternity hospitals that discontinued their services and those funded after 1997.
** The calculated number of clusters is the number of study days in each hospital and was calculated as the ratio of the 
calculated sample size of postpartum women by the number of daily deliveries in a city, without adjusting for the expected 
prevalence of prenatal care coverage rate.
a Integrated Microcomputer Processing System [software online]. United States Census Bureau. [cited 2008 Aug 19] Available from: 
http://www.census.gov/ipc/www/imps/index.html
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In order to account for the effects of a complex sam-
pling design, analyses were performed using SAS13 
version 8.2 and SUDAAN (SAS callable) version 8.17 
Descriptive statistics were generated for all study vari-
ables. Bivariate analyses were conducted to assess the 
relationship between offering and uptake of HIV testing 
and potential explanatory variables – age, race, level of 
education, formal employment, monthly income, previ-
ous knowledge about the importance of knowing one’s 
HIV status and its potential benefi ts to the child (“pre-
vious knowledge”), primiparity (vs. previous birth[s]), 
trimester of fi rst prenatal visit, number of prenatal visits, 
and utilization of a public primary care unit for prenatal 
care. Moreover, there was a concern with capturing the 
effects of differences among the cities studied on the 
outcomes. Counseling and testing offering were con-
sidered in the explanation of testing uptake.
Multivariate logistic regression models were developed 
to assess the independent effects of the variables on 
HIV testing offering and uptake.
The National Research Ethics Committee approved the 
study protocol and all participating women signed an 
informed consent.
RESULTS
A total of 2,234 women were interviewed, 96.5% of 
the total sample size, who were selected from the study 
eligible population of 20,886 women.
Mean age was 25 years and half of the interviewees 
were non-white. Most reported 8 or less years of 
education and having received prenatal in a public pri-
mary care service. The large majority reported that the 
fi rst prenatal care visit occurred during the fi rst (66.5%) 
or the second trimester (27.6%) of pregnancy. Most of 
them reported they had attended at least six prenatal 
care visits. Knowledge about AIDS and awareness 
about the importance of HIV testing for PMTCT was 
reported by 92.6% and 85.2% of the women, respec-
tively (Table 2).
Overall, 77.5% of the women reported undergoing HIV 
testing during the current pregnancy. Of them, 13.8% 
(1.2% – 21.8%) reported they had been tested during 
routine prenatal screening tests without their prior 
knowledge or consent.
Among those who were offered HIV testing, 92.5% 
accepted it, but only 37.5% were informed they could 
choose not to take it. In addition, among those who re-
ceived their HIV testing result, only 47.4% reported they 
were explained the meaning of the HIV testing result.
Regarding information about HIV prevention, only 50% 
of the women surveyed reported they had received it. A 
previous HIV testing at any point in lifetime before the 
current pregnancy was reported by 26.4%. Ta
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The bivariate analyses showed that years of education, 
previous knowledge about HIV testing for PMTCT, 
number of prenatal care visits and cities were signifi -
cantly associated with testing offering and uptake. In 
addition, testing uptake was also signifi cantly associ-
ated with race, monthly income, primiparity, trimester 
of fi rst prenatal care visit, counseling and testing of-
fering. Table 3 shows the fi ndings of cross-analyses 
between testing offering and uptake and potential 
explanatory variables.
The multivariate logistic regression model for HIV 
testing offering is shown in Table 4. Offering of HIV 
testing was found to be positively associated with 
being white (borderline signifi cance, p=0.0655), hav-
ing more years of formal education, having previous 
knowledge about the importance of HIV testing for the 
prevention of HIV vertical transmission, and having a 
higher number of prenatal care visits. The interaction 
effect of being white and having previous knowledge 
about the importance of HIV testing was found to be 
negative. The cities Duque de Caxias, Uruguaiana, and 
Curitiba did not differ signifi cantly from the city of Rio 
de Janeiro, which was the fi rst city to implement large-
scale PMTCT training of health care workers. For this 
reason, these cities were taken as the reference group 
in the analysis. In the cities São Paulo, Florianópolis, 
Porto Alegre, Campo Grande, and Brasília, testing 
offering was signifi cantly lower than in the reference 
group. The cities of Santos, Sorocaba, and Itajaí had a 
higher testing offering vis-à-vis all other cities.
We made several attempts to fi t a model for testing 
uptake but unsuccessfully. This is probably because 
‘testing offering’ explained most of the variation in 
test uptake (OR=35.31) (Hosmer-Lemeshow test, 
p=0.2084). Nonetheless, the study data indicate that 
counseling and total number of prenatal care visits do 
had a positive effect on testing uptake.
DISCUSSION
The results showed that, in spite of receiving prenatal 
care, almost one-fourth of the women went through 
pregnancy without being tested. Unaware of their 
status, these women were unable to benefi t from inter-
ventions available in Brazil to reduce mother-to-child 
HIV transmission.
Several studies have already demonstrated that minority 
populations have more diffi cult access to health care, 
even when it is free.1,20,21 This seems to be the case of 
HIV counseling and testing during pregnancy in Brazil. 
It was found a lower rate of HIV testing offering among 
non-white women, those with lower level of education 
and those attending fewer prenatal care visits when com-
pared to white women, those with intermediate or higher 
level of education, and those attending a higher number 
of prenatal care visits. This is a matter of concern, 
since in Brazil the HIV/AIDS epidemic has primarily 
affected the poor, especially those with lower education 
and belonging to the Black population.5 Education and 
prenatal care were found to be determinants for being 
tested in several studies conducted in developed and 
developing countries, including Brazil.10,16
In developed countries, the lack of testing offering is 
known to be one of the main reasons for pregnant women 
not to receive HIV testing.10 Although most obstetricians 
support HIV testing in prenatal care, they often rely on 
their perceptions about women’s risk.19 Insuffi cient time 
and training and the sensitive nature of discussing issues 
related to HIV infection may also prevent providers from 
offering HIV testing to pregnant women.3
Since there are now available effective interventions to 
reduce HIV transmission from mother to child to below 
2%, failure to offering HIV testing to pregnant women 
and appropriate interventions for those infected should 
be considered negligence.
The fi nding of 92.5% of HIV testing acceptance is reas-
suring. Similar rates of acceptance were also found in 
other studies conducted in Brazil, including when HIV 
testing was offered during labor.6,9,12 The wide availabil-
ity of free HIV prevention and care services in Brazil, 
which includes highly potent antiretroviral therapy and 
HIV testing, as well as the policy of universal offering 
of HIV testing to pregnant women would be among 
the several factors contributing to the high rate of HIV 
testing acceptance seen in the present study.
The high proportion of women (14%) who reported 
they were HIV tested as part of prenatal care routine 
tests whithout being informed raises concern. In ad-
dition, among those women to whom HIV testing 
was offered, less than two-thirds were informed they 
had the right to refuse it. This practice can explain 
a higher number of women tested for HIV than the 
number of women offered testing in the cities of São 
Paulo, Sorocaba, Curitiba, and Porto Alegre. A large 
study conducted in Porto Alegre for one year during 
the same period covered by the present study also 
found a high proportion of unawareness of being 
tested/compulsory HIV testing.9 The literature review 
we carried out did not fi nd any study in the other three 
cities adressing the issue of compulsory HIV testing. In 
a study performed in Spain to compare self-reporting 
with medical record information regarding HIV test-
ing, unawareness of having been tested was found in 
10.7% of the study population.
Although it is unquestionable that HIV testing would 
be benefi cial to all pregnant women, they must not be 
tested without their knowledge and have the right to be 
informed to make decisions about their health.
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Table 3. Bivariate analyses crossing testing offering and uptakewith explanatory variables. Brazil, 1999–2000.
Variable
HIV testing offered HIV test uptake
Yes (%) No (%) χ2 (p) Yes (%) No (%) χ2 (p)
Age 0.6887 0.1348
<18 72.3 27.7 79.5 20.5
18–30 73.8 26.2 76.5 23.5
>30 75.5 24.5 80.8 19.2
Race 0.8496 0.0361
White 74.2 25.8 80.0 20.0
Non-white 73.7 26.3 75.4 24.6
Years of education 0.0039 <0.0001
<5 67.0 33.0 69.0 31.0
5–8 74.7 25.3 79.0 21.0
>8 78.6 21.4 82.3 17.7
Missing 87.2 12.8 87.2 12.8
Previous knowledge about HIV testing for 
prevention of mother-to-child transmission
0.0502 0.0446
Yes 75.1 24.9 78.5 21.5
No 67.5 32.5 71.8 28.2
Employed 0.1715 0.2749
Yes 76.6 23.4 79.5 20.5
No 73.3 26.7 77.1 22.9
Monthly income (R$) 0.1548 0.0001
≤500.00 72.4 27.6 74.5 25.5
>500.00 76.1 23.9 81.9 18.1
Primiparity 0.2541 0.0178
Yes 75.4 24.6 80.2 19.8
No 73.0 27.0 75.7 24.3
Trimester of fi rst prenatal care visit 0.4298 0.0054
1st 74.4 25.6 79.8 20.2
2nd 74.6 25.4 74.9 25.1
3rd 63.5 36.5 64.2 35.8
Missing 73.7 26.3 66.7 33.3
Number of prenatal care visits 0.0038 <0.0001
1–2 56.1 43.9 52.2 47.8
3–5 70.3 29.7 70.1 29.9
>5 76.4 23.6 81.8 18.2
Prenatal care at primary care unit 0.9266 0.6420
Yes 73.9 26.1 77.9 22.1
No 74.1 25.9 76.8 23.2
City <0.0001 <0.0001
Rio de Janeiro 81.6 18.4 74.7 25.3
Duque de Caxias 88.9 11.1 85.0 15.0
São Paulo 70.4 29.6 80.8 19.2
Santos 96.1 3.9 94.4 5.6
Sorocaba 89.7 10.3 91.1 8.9
Curitiba 82.5 17.5 87.7 12.3
Florianópolis 74.5 25.5 66.4 33.6
Itajaí 90.1 9.9 88.9 11.1
Porto Alegre 62.4 37.6 90.5 9.5
Uruguaiana 85.3 14.7 69.8 30.2
Campo Grande 50.3 49.7 47.7 52.3
Brasília 70.1 29.9 65.0 35.0
Counseling <0.0001
Yes 89.6 10.4
No 67.0 33.0
Testing offered <0.0001
Yes 92.7 7.3
No 34.6 65.4
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Another reason for concern is the high proportion of 
women who reported not receiving any information 
on the meaning of the HIV testing result. Hence, this 
prompts to question the quality of HIV voluntary coun-
seling and testing provided in Brazil. Studies conducted 
in São Paulo and Porto Alegre also identifi ed the sub-
optimum quality of HIV counseling.6,15
In the present study there was seen an association be-
tween knowledge about the importance of HIV testing 
for PMTCT and the likelihood of being offered HIV 
testing. In England, it was shown that any discussion of 
HIV transmission related to pregnant women increased 
the likelihood of testing.4,8
In the literature, there is strong evidence of the impact of 
disseminating sound and culturally-sensitive informa-
tion on the increase in the uptake of health interventions 
among disadvantaged populations.14 Women with 
adequate knowledge about the availability of inter-
ventions to prevent HIV mother-to-child transmission 
were found to be more likely to have received an HIV 
testing, regardless of race/ethnicity, age, education or 
number of previous births.11 Dissemination of informa-
tion focusing women more vulnerable to not be offered 
HIV testing in Brazil may signifi cantly contribute to 
increased rates of testing coverage.
Although the attempts to fi t a model to explain HIV 
testing uptake were unsuccessful, the study fi ndings 
suggest that counseling contribute to increase HIV 
testing uptake.
Among the main strengths of the present study is its 
large population-based random sample, calculated 
independently for each city. Furthermore, choosing 
Table 4. Logistic regression model for explanation of the variation in HIV testing offering to pregnant women. Brazil, 
1999–2000.
Variable
Coeffi cient 
estimate
Standard 
error
Wald test
(p)
Odds ratio 
estimate
95% Wald con-
fi dence interval
Intercept 0.80 0.23 0.0005
Race
White 0.52 0.28 0.0655 1.67 0.97;2.90
Non-white 
Years of education
<5 (ref)
5-8 0.34 0.16 0.0363 1.40 1.02;1.92
>8 0.48 0.17 0.0051 1.61 1.16;2.25
Previous knowledge about HIV infection for prevention of mother-to-child transmission
Yes 0.62 0.24 0.0097 1.86 1.16;2.96
No (ref)
Interaction of race and previous knowledge about HIV testing uptake
White and “previous knowledge” –0.58 0.29 0.0435 0.56 0.32;0.98
Non-white or no “previous knowledge” 
Number of prenatal care visits
1–2 –0.69 0.28 0.0149 0.50 0.29;0.87
≥3 (ref)
City 
São Paulo –0.73 0.24 0.0027 0.48 0.30;0.78
Santos 1.55 0.63 0.0142 4.73 1.37;16.32
Sorocaba 0.69 0.36 0.0586 1.99 0.98;4.07
Florianópolis –0.58 0.21 0.0062 0.56 0.37;0.85
Itajaí 0.75 0.38 0.0514 2.12 1.00;4.49
Porto Alegre –1.12 0.47 0.0192 0.33 0.13;0.83
Campo Grande –1.49 0.26 <0.0001 0.23 0.13;0.38
Brasília –0.76 0.17 <0.0001 0.47 0.33;0.65
[Rio de Janeiro; Duque de Caxias; Curitiba; and 
Uruguaiana] (ref) 
Hosmer-Lemeshow goodness-of-fi t test (p) = 0.2084
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postpartum women allowed to gathering data about 
interventions received during the entire prenatal care 
period. In Brazil, births take place predominantly in 
hospitals. In the year 2000, only 1.4% of the deliveries 
occurred outside hospitals, and home delivery is un-
common in the cities included in the study.7
Among limitations of the study, HIV testing data were 
based on self-reports. However, while recall bias can-
not be excluded, it is unlikely that patients would not 
recall their testing and counseling experiences related to 
the current pregnancy. Also, it cannot be excluded that 
some women assumed they were tested for HIV, when 
they were not. Another point to consider is that women 
under 18 years of age were not adequately represented 
in the study population, as the Brazilian law does not 
allow them to be enrolled in such studies.
In conclusion, Brazil continues to face a huge challenge 
to prevent mother-to-child transmission of HIV infec-
tion. In spite of the high rate of HIV testing acceptance 
among pregnant women, one-fourth of the women 
attending prenatal care has not been tested for HIV 
or even have been offered it. The study data indicate 
that dissemination of information about prevention 
of mother-to-child transmission among women may 
contribute to increase HIV testing coverage during 
pregnancy. Non-white women with lower education 
should be prioritized. In addition, strategies to increase 
attendance rates of vulnerable populations to prenatal 
care visits as well as to sensitize and train health care 
workers to systematically offer HIV testing in prenatal 
care are of utmost importance to overcome the barriers 
to prevent HIV infection among children.
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